SKI Market

Indian Indices

Sensex

83,294.66 479.95
( 0.58%)

Global Indices

Nasdaq

48,816.07 -830.91
(-1.67%)

Dow Jones

6,858.07 -72.44
(-1.05%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,664.46 -22.43
(-0.21%)

Forex

USD-INR

91.03 0.34
(0.37%)

EUR-INR

107.23 0.00
(0.00%)

GBP-INR

122.67 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

267.3488556

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

29.85

15152.07

EPS(TTM)

Face Value()

Div & Yield %

25.82

1.43

Back

Amerise Biosciences reports standalone net loss of Rs 0.04 crore in the September 2025 quarter

Nov 05,2025

Net Loss of Amerise Biosciences reported to Rs 0.04 crore in the quarter ended September 2025 as against net loss of Rs 0.03 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.

83,294.66 479.95 ( 0.58%)

48,816.07 -830.91 (-1.67%)

6,858.07 -72.44 (-1.05%)

56,838.27 -629.56 (-1.10%)

10,664.46 -22.43 (-0.21%)

91.03 0.34 (0.37%)

107.23 0.00 (0.00%)

122.67 -0.16 (-0.13%)

0.59 0.00 (-0.25%)